- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02493309
FIT 2 SIT - Are Metabolic Responses to Sitting/Light Breaks Mediated by Fitness? (FIT2SIT)
The Impact of Cardio-respiratory Fitness on an Individual's Metabolic Response to Sitting and Light Activity Breaks
The purpose of this study is to determine whether an individuals cardio-respiratory fitness level can protect them from the negative metabolic impacts of prolonged sitting time.
Overall, it is hypothesised that in individuals with high fitness, the unfavourable effect of prolonged sitting (build up of sugar, fat and insulin in the blood following a meal) will not be as substantial, nor will light activity breaks be as advantageous, compared to individuals with lower fitness as they have a smaller scope for metabolic improvement.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The FIT 2 SIT study requires three separate study visits in total.
At visit one, we will check the participants blood pressure, height, weight, waist measurement and body fat percentage, we will also take a blood sample to measure HbA1c and cholesterol, all of which will help confirm that this participant is eligible to continue in this study (some may be excluded based on results of the above). We will also measure the amount of energy participants expend per minute while at rest and during a slow walking task (3km.h on a treadmill) using a gas mask technique. Energy responses to sitting and walking differ between individuals, therefore it is of interest to observe how each participant in this study responds to these conditions as it may help explain any potential findings of this study. For instance, introducing walking breaks (by way of reducing sitting time) may only benefit those who have consequent increases in energy expenditure as a result of these breaks. Lastly, to mark the end of the first study visit, participants will be asked to perform an exercise test based on a treadmill to assess their fitness level. whilst running a special mask covering the nose and mouth will be worn to analyse breathing, this will be connected to a machine (gas analyser) that gives information on the amount of oxygen participants breathe in and out. The point at which the amount of oxygen they breathe in remains stable despite increases in exercise difficulty is the point that we will stop the exercise test because this tells us that they have reached their exercise capacity (called V02max), and from this we can determine fitness level.
Following this first visit we will have fitness level data from all participants. Recruiting participants with a diverse fitness level will then help to elucidate the role that an individuals fitness has on their response to the following treatment conditions.
Treatment condition A is referred to as the 'sitting' condition. Here participants will remain seated throughout the whole of the 7 ½ hour test period (8am - 3:30pm) whilst watching TV/DVD's, reading, using the internet, doing paperwork etc. at their will. On arrival, participants will have a cannula (a small tube that allows us to take blood) inserted into their arm; this will stay in the arm and allow us to take regular blood samples throughout the day, without the need for multiple needles. After we take the first blood sample, participants will sit quietly for an hour. We will then provide breakfast. Whilst sitting, we will take blood samples (using the cannula) and blood pressure at 30, 60, 120 and 180 minutes after breakfast. We will then provide a lunch meal and will continue taking blood samples and blood pressure at 30, 60, 120, 180 and 210 minutes after this lunch meal. In total, we will take 11 blood samples over the 7 ½ hour testing period. Although this may sound a lot, it is equivalent to around 8-9 teaspoons of blood over the course of the day.
Condition B is the 'light activity breaks' condition. Participants will go through exactly the same process as condition A but will also be asked to do 5 minute bouts of slow walking on a treadmill every 30 minutes following breakfast and lunch. In total they will do 12 five minute walks on the treadmill throughout the 7 ½ hour test period (60 minutes of walking in total). In total, we will take 11 blood samples on the day.
With data on each participants metabolic response to a meal during A) prolonged sitting and B) during an interrupted sitting condition, we can see how fitness influenced the results.
However, at present, the absence of laboratory randomised crossover trials assessing the 'extent' to which fitness moderates the relationship between sedentary behaviour and metabolic health markers appear absent from the literature, warranting further investigation, which is why this design was chosen.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Leicestershire
-
Leicester, Leicestershire, United Kingdom, LE5 4PW
- Leicester Diabetes Centre, Leicester General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the study
- Body Mass Index: 20 - 30 kg/m2
- Male and Female
- Aged: ≥ 25 to ≤ 55 years of age.
- Occupation: Work full-time in a predominantly sedentary occupation.
Exclusion Criteria:
Due to the nature of the trial, our exclusion criteria are as follows:
The participant may not enter the study if ANY of the following apply:
- Aged <25 or >55 years of age.
- Physical condition which limits full participation in the study
- Active psychotic illness or other significant illness which, in the view of the investigators, would prevent full participation
- Inability to communicate in spoken English
- Steroid use
- Known Type 2 Diabetes
- Pre-existing Cardio-vascular Disease (disease of the heart or blood vessels at present or in the past) For example: Heart attack, Stroke or Angina.
- Pregnancy
- Smoker
- Terminal illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prolonged sitting
|
Condition A is referred to as the 'sitting' condition.
Here participants will remain seated throughout the whole of the 7 ½ hour test period (8am - 3:30pm).
On arrival, participants will have a cannula (a small tube that allows us to take blood) inserted into their arm; this will stay in the arm and allow us to take regular blood samples throughout the day.
Blood samples and blood pressure will be taken at 30, 60, 120 and 180 minutes after breakfast.
We will then provide a lunch meal and will continue taking blood samples and blood pressure at 30, 60, 120, 180 and 210 minutes after this lunch meal.
In total, we will take 11 blood samples over the 7 ½ hour testing period.
|
|
Active Comparator: Light activity breaks
|
Condition B is the 'light activity breaks' condition.
Participants will go through exactly the same process as condition A but will also be asked to do 5 minute bouts of slow walking on a treadmill every 30 minutes following breakfast and lunch.
In total they will do 12 five minute walks on the treadmill throughout the 7 ½ hour test period (60 minutes of walking in total).
In total, we will take 11 blood samples on the day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose Area Under the Curve (AUC)
Time Frame: Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
|
Blood glucose AUC refers to the spike of an individuals blood sugar following a meal, the aim of which is to reduce the spike and consequently reduce the area under the curve.
|
Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Triglyceride AUC
Time Frame: Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
|
Refers to an individuals triglyceride response to a meal over a prolonged time period during each treatment.
|
Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
|
|
Insulin AUC
Time Frame: Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
|
Refers to an individuals insulin response to a meal over a prolonged time period during each treatment.
|
Assessed via 11 blood samples throughout each treatment condition throughout the 7.5 hour period
|
|
Blood Pressure
Time Frame: Taken immediately before each blood sample is taken.
|
Taken immediately before each blood sample is taken.
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 0458
- CRN151741 (Other Identifier: Registry ID: UK Clinical Research Network)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
DiappyMedSanoiaRecruitingDiabetes Type 1 | Pancreatogenous Diabetes | Diabetes Type 2 on InsulinFrance
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
Clinical Trials on Prolonged sitting
-
National Taiwan Normal UniversityDivision of Endocrinology and Metabolism, Tri-Service General HospitalCompletedCognition | Energy Balance | Metabolic Health | Physical Activity LevelTaiwan
-
University of Texas at AustinCompletedAtherosclerosis | Metabolic SyndromeUnited States
-
The Swedish School of Sport and Health SciencesThe Knowledge Foundation; ICA-gruppen; Intrum AB; SATS; Monark Exercise; ItrimCompleted
-
University of BathMinistry of Education, TaiwanCompletedInsulin Sensitivity
-
University of Texas at AustinCompletedAtherosclerosis | Metabolic SyndromeUnited States
-
University of Texas at AustinCompletedCardiovascular Diseases | Vascular Diseases | Glucose Metabolism Disorders | Arteriosclerosis | Arterial Occlusive Diseases | Atherosclerosis | Insulin Resistance | Hyperinsulinism | Metabolic Syndrome X | Metabolic DiseaseUnited States
-
The Swedish School of Sport and Health SciencesThe Knowledge Foundation; IKEA; Skandia; Konsumentföreningen Stockholm; Generation... and other collaboratorsCompleted
-
University of BedfordshireRecruitingCardiovascular DiseasesUnited Kingdom
-
University of LeicesterUniversity Hospitals, Leicester; Loughborough University; Baker Heart and Diabetes...CompletedType 2 Diabetes MellitusUnited Kingdom
-
University of ExeterUniversity of British ColumbiaTerminatedEndothelial Dysfunction | Cardiovascular Risk FactorUnited Kingdom